Biogenic Silver Nanoparticle Data for Osteomyelitis Treatment

A 181.3 KB PDF details a novel green nanoparticle formulation with dual antibacterial and bone-growth-promoting actions. The data, authored by Munirah F. Aldayel, includes results from a Staphylococcus aureus-induced mouse model of osteomyelitis. It was last updated on May 26, 2026, and is shared under a CC-BY-4.0 license.

Use Cases

• Training models to predict antibacterial efficacy based on nanoparticle synthesis methods described.
• Analyzing the relationship between nanoparticle treatment and osteocalcin-positive osteoblast activity mentioned in the results.
• Studying the synergistic effects of plant extract and silver nanoparticles on biofilm suppression as detailed in the description.

Strengths

• Data is peer-reviewed research from a specific in vivo mouse model for osteomyelitis.
• The 181.3 KB PDF provides detailed methodological and result descriptions for reproducibility.
• The dataset is openly licensed under CC-BY-4.0, permitting reuse and redistribution.

Limitations

• The dataset is a single 181.3 KB PDF document, offering limited scope for computational analysis.
• Column-level documentation is absent; field semantics must be inferred from the text.
• Row count is unknown, which may limit suitability assessment for large-scale modeling.

Provenance

Source

figshare, authored by Munirah F. Aldayel.

Collection Method

Data originates from a laboratory study involving phytosynthesis of silver nanoparticles and a mouse model.

Freshness

Last updated 2026-05-26 04:37:02; freshness should be verified.